| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.59▲ | 1.57▲ | 1.58▲ | 1.68▼ | 1.62▼ |
| MA10 | 1.58▲ | 1.58▲ | 1.61▼ | 1.69▼ | 1.57▲ |
| MA20 | 1.58▲ | 1.62▼ | 1.65▼ | 1.61▼ | 1.48▲ |
| MA50 | 1.61▼ | 1.67▼ | 1.69▼ | 1.55▲ | 5.90▼ |
| MA100 | 1.65▼ | 1.68▼ | 1.64▼ | 1.48▲ | 10.04▼ |
| MA200 | 1.69▼ | 1.62▼ | 1.62▼ | 4.46▼ | 13.83▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.006▲ | -0.001▼ | -0.010▼ | -0.006▼ | 0.381▲ |
| RSI | 50.103▲ | 37.781▼ | 36.666▼ | 47.998▼ | 34.137▼ |
| STOCH | 49.074 | 20.678 | 11.223▼ | 49.614 | 68.816 |
| WILL %R | -44.444 | -70.000 | -75.000 | -66.667 | -39.474 |
| CCI | 113.021▲ | -23.419 | -72.598 | -51.697 | 88.789 |
|
Thursday, August 07, 2025 01:05 PM
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in integrin-based drug development, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/09/25 | 1.67 | 1.69 | 1.56 | 1.59 | 475,212 |
| 11/09/25 | 1.68 | 1.70 | 1.6408 | 1.65 | 290,419 |
| 10/09/25 | 1.83 | 1.8477 | 1.67 | 1.69 | 351,480 |
| 09/09/25 | 1.70 | 1.78 | 1.66 | 1.75 | 487,534 |
| 08/09/25 | 1.85 | 1.85 | 1.68 | 1.73 | 924,778 |
| 05/09/25 | 1.62 | 1.89 | 1.61 | 1.86 | 3,423,935 |
| 04/09/25 | 1.71 | 1.71 | 1.60 | 1.63 | 154,188 |
| 03/09/25 | 1.66 | 1.73 | 1.64 | 1.71 | 749,076 |
| 02/09/25 | 1.61 | 1.68 | 1.58 | 1.675 | 392,762 |
| 29/08/25 | 1.62 | 1.64 | 1.54 | 1.64 | 517,819 |
|
|
||||
|
|
||||
|
|